A Study of Herceptin (Trastuzumab)and Biomarkers in Patients With HER2-Positive Metastatic Breast Cancer
Clinical trial NCT00885755 · COMPLETED
Trial details
- NCT number
- NCT00885755
- Sponsor
- Hoffmann-La Roche
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2009-08-13
- Primary completion
- 2013-02-18
- Enrollment
- 33
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.